EU and UK Regulators Found Links Between AstraZeneca’s COVID-19 Vaccine and Blood Clots
LONDON (Reuters) – Italy recommended on Wednesday that AstraZeneca’s COVID-19 shot only be used on those over 60 and Britain that people under 30 should get an alternative, due to possible links between the vaccine and very rare cases of blood clots.
More than a dozen countries have at one time suspended the use of the vaccine, which has been given to tens of millions in Europe. But most have resumed, with some, including France, the Netherlands, and Germany, recommending a minimum age.
European Union health ministers failed to agree with common guidance on the use of the shot, despite calls for coordination across member states to combat public hesitancy over a vaccine set to be a key component of many vaccination programs.
Italy’s health authority recommended that the shot only be used on people over 60 years old but said those under 60 who have taken a first AstraZeneca shot can also take a second one.
